An insurance lobbyist hopes at least to win legislation next year allowing the state to negotiate drug prices for Medicaid patients, and requiring drug companies to disclose more information about their pricing, as a means to control pharmaceutical costs. Price controls, said Paul Sanford of the Florida Insurance Council, would be a much bigger lift, […]